ANDO GORAN 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jun 22, 2023
Insider Transaction Report
Form 4
ANDO GORAN
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-20+13,500→ 13,500 totalExercise: $3.50From: 2024-02-23Exp: 2033-06-19→ Common Stock (13,500 underlying) - Award
Stock Option (Right to Buy)
2023-06-20+27,100→ 27,100 totalExercise: $3.26From: 2024-01-06Exp: 2033-06-19→ Common Stock (27,100 underlying)